Robert Boldy
Internal Medicine · Apple Valley, CANPI 1063507382
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.8% of the total across 76 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 18.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,598 and has fallen 99.3% since, to $18 in 2023. Among internal medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $56.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$805
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$492
- Amgen$341
- Dexcom, Inc.$278
- Novo Nordisk$255
- Regeneron Healthcare Solutions, Inc.$250
- plus $2K from 19 others
What the payments were for
- Food & beverage$4,305100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 30 | $805 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $492 |
| Amgen | 5 | $341 |
| Dexcom, Inc. | 2 | $278 |
| Novo Nordisk | 4 | $255 |
| Regeneron Healthcare Solutions, Inc. | 2 | $250 |
| Neurocrine Biosciences, Inc. | 2 | $249 |
| Merck | 2 | $217 |
| Boehringer Ingelheim | 2 | $153 |
| GSK | 2 | $147 |
| Hologic Sales And Service, LLC | 1 | $125 |
| Amarin Pharma, Inc. | 1 | $125 |
| Intercept Pharmaceuticals, Inc. | 1 | $121 |
| AstraZeneca | 4 | $117 |
| Ironshore Pharmaceuticals Inc. | 2 | $114 |
| Biodelivery Sciences International, Inc. | 1 | $105 |
| Sanofi-aventis U.S. LLC | 1 | $100 |
| Alkermes, Inc. | 1 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $96 |
| Sanofi Pasteur Inc. | 2 | $33 |
| Pfizer | 1 | $26 |
| Mannkind Corporation | 1 | $22 |
| AbbVie | 1 | $19 |
| Phadia US Inc. | 1 | $13 |
| Teva Pharmaceuticals USA, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXCOM G6 TRANSMITTER$278
- DUPIXENT$250
- INGREZZA$249
- STEGLATRO$217
- Repatha$125
- Cervical Cancer Screening$125
- Ozempic$125
- RYBELSUS$125
- Vascepa$125
- JARDIANCE$125
- TRELEGY ELLIPTA$125
- XIFAXAN$115
- Jornay PM 20mg capsules (Bottle of 100)$109
- BELBUCA$105
- LUCEMYRA$100
- TRULICITY$100
- TRULANCE$100
- TOUJEO$100
How this compares
$4,314 in reported general payments places this provider in the 90th percentile of 13,581 internal medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 28 | $580 |
| Hydrochlorothiazide | 17 | $133 |
| Amlodipine Besylate | 22 | $122 |
| Metformin Hcl | 12 | $115 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Apple Valley
- Andrew ChengSouth San Francisco$55.1M
- Tung NgoNewport Beach$4.9M
- Christian EversullStanford$2.9M
- Christian SandrockSacramento$2.1M
- Hatim HusainSan Diego$2M
- Teck LingPalo Alto$1.1M
- Hyong Kimla Jolla$1M
- Rohit Loombala Jolla$965K
- Fred CohenSan Francisco$929K
- Steven EdelmanSan Diego$863K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.